Journal of Affective Disorders
Volume 91, Issue 1 , Pages 27-32 , March 2006

Burden of phase-specific sexual dysfunction with SSRIs

  • Anita Clayton

      Affiliations

    • Department of Psychiatric Medicine, University of Virginia, Charlottesville, VA, USA
    • Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, VA, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 434 243 4646; fax: +1 434 243 4743.
    • ,
  • Adrienne Keller

      Affiliations

    • Department of Psychiatric Medicine, University of Virginia, Charlottesville, VA, USA
    • Department of Health Evaluation Sciences, University of Virginia, Charlottesville, VA, USA
    • ,
  • Elizabeth L. McGarvey

      Affiliations

    • Department of Psychiatric Medicine, University of Virginia, Charlottesville, VA, USA

Received 11 April 2005 ,Revised 18 November 2005 ,Accepted 7 December 2005.

References 

  1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorder. Fourth Edition. Washington, DC: American Psychiatric Press; 1994;
  2. Argiolas A, Melis MR. The neurophysiology of the sexual cycle. J. Endocrinol. Investig. 2003;26(3 Suppl):20–22
  3. Bobes J, Gonzalex MP, Rico-Villademoreos F, et al. Validation of the Spanish version of the Changes in Sexual Functioning Questionnaire—CSFQ. J. Sex Marital Ther. 2000;26:119–131
  4. Boyarshk BK, Hague W, Rouleau MR, Hirshfled RMA. Sexual functioning in depressed outpatients taking mirtzapine. Depress. Anxiety. 1999;9:175–179
  5. Cassano P, Fava M. Tolerability issues during long-term treatment with antidepressants. Ann. Clin. Psychiatry. 2004;16(1):15–25
  6. Clayton AH, Owens , McGarvey EL. Assessment of paroxetine-induced sexual dysfunction using the Changes in Sexual Functioning Questionnaire. Psychopharmacol. Bull. 1995;31(2):397–413
  7. Clayton AH, McGarvey EL, Clavet GJ. The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity. Psychopharmacol. Bull. 1997;33(4):731–745
  8. Clayton AH, McGarvey EL, Clavet GJ, Piazza L. Comparison of sexual functioning in clinical and nonclinical populations using the Changes in Sexual Functioning Questionnaire (CSFQ). Psychopharmacol. Bull. 1997;33(4):747–753
  9. Clayton AH, Pradko JF, Croft HA, Montano CB, Leadbetter RA, Bolden-Watson C, et al. Prevalence of sexual dysfunction among newer antidepressants. J. Clin. Psychiatry. 2002;63:357–366
  10. Ferguson JM. The effects of antidepressants on sexual functioning in depressed patients: a review. J. Clin. Psychiatry. 2001;62(Suppl 3):22–34
  11. Foreman MM, Fuller RW, Nelson DL, Calligaro DO, Kurtz KD, Misner JW, et al. Preclinical studies of LY237733, a potent and selective serotonergic antagonist. J. Psychopharmacol. Exper. Ther. 1992;260:51–57
  12. Geddes JR, Freemantle N, Mason J, Eccles MP, Boynton J. SSRIs versus other antidepressants for depressive disorder. In: The Cochrane Library, Issue. vol. 4:Oxford: Update Software; 2000;
  13. Gitlin M. Sexual dysfunction with psychotropic drugs. Expert Opin. Pharmacother. 2003;4(12):2259–2256
  14. Gregorian RS, Golden KA, Bahce A, Goodman C, Kwong WJ, Khan J, et al. Antidepressant-induced sexual dysfunction. Ann. Pharmacother. 2002;36(10):1577–1589
  15. Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. J. Clin. Psychiatry. 2000;61(4):276–281
  16. Masand PS, Gupta S. Long-term side effects of newer-generation antidepressants: SSRIs, venlafaxine, nefazodone, bupropion, and mirtazapine. Ann. Clin. Psychiatry. 2002;14(3):175–182
  17. Montejo-Gonzalez AK, Llorca G, Izquierdo JA, Ledesma A, Bousono M, Calcedo A, et al. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertaline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J. Sex Marital Ther. 1997;23:176–194
  18. Nurnberg GH. Erectile dysfunction and comorbid depression: prevalence, treatment strategies and associated medical conditions. J. Clin. Psychiatry. 2003;64(suppl 10):3–10
  19. Physician's Desk Reference . Physician's Desk Reference. New Jersey: Medical Economics Data; 1998;
  20. Roose SP. Tolerability and patient compliance. J. Clin. Psychiatry. 1999;60(suppl. 17):14–17
  21. Segraves RT. Antidepressant-induced sexual dysfunction. J. Clin. Psychiatry. 1998;59(suppl. 4):48–54
  22. Worthington JJ, Peters PM. Treatment of antidepressant-induced sexual dysfunction. Drugs Today. 2003;39(11):887–896

☆ Some of the information in this paper appeared as part of a poster presentation at the American Psychiatric Association annual meeting in San Francisco, CA, May 2003. This work was done at the Department of Psychiatric Medicine, University of Virginia, Charlottesville, Virginia.

PII: S0165-0327(05)00376-9

doi: 10.1016/j.jad.2005.12.007

Journal of Affective Disorders
Volume 91, Issue 1 , Pages 27-32 , March 2006

Article Tools